TIM3+CD8+ T细胞在非小细胞肺癌中心区和非中心区微环境中的表达及其临床意义
Jiajuan WU, Shiying GUO, Leilei LV, Jiawei ZHAI, Yu SHEN, Cheng CHEN, Qiuxia QU · 2024
Read TIM3+CD8+ T细胞在非小细胞肺癌中心区和非中心区微环境中的表达及其临床意义 by Jiajuan WU, Shiying GUO, Leilei LV, Jiawei ZHAI, Yu SHEN, Cheng CHEN, Qiuxia QU (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11839502.txt.
Description
Jiajuan Wu and co-authors study a marked subset of killer T cells in lung cancer tissue, in a paper from 2024. The cancer in question is the non small cell type, the most common form of lung cancer. Immune checkpoint drugs are a main treatment for it, yet only a small share of patients answer well, so better markers of likely response are needed.
Tumor samples were split into central and non central regions. Flow based tests counted T cells carrying a marker called TIM3 and checked a second brake marker on their surface. The team then related those counts to how well patients answered immune therapy. A marker that sorts likely responders could help doctors aim the drugs at the patients most apt to gain from them.
Catalog record
| CREATOR | Jiajuan WU, Shiying GUO, Leilei LV, Jiawei ZHAI, Yu SHEN, Cheng CHEN, Qiuxia QU |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 21 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |